Health Care: Drugs

Enanta Pharmaceuticals Inc (ENTA: NASDAQ)

$33.04 -0.19 | -0.57%
01/24/17 - 04:00 PM ET
Company Income Statement
Sep 2016 Sep 2015 Sep 2014 Sep 2013
Sales 88.27M 160.88M 47.74M 32.05M
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 88.27M 160.88M 47.74M 32.05M
Selling, General, and Administrative Expenses 16.97M 13.54M 10.02M 6.18M
Research & Development 40.46M 23.19M 18.74M 16.84M
Operating Income before D & A (EBITDA) 30.84M 124.15M 18.98M 9.03M
Depreciation & Amortization 3.17M 2.88M 2.47M 1.48M
Interest Income 1.74M 968.00K 467.00K 248.00K
Other Income - Net 29.00K 347.00K -166.00K 381.00K
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) 29.43M 122.58M 16.81M 8.18M
Interest Expense 45.00K 8.00K 18.00K 31.00K
Pre-Tax Income 29.39M 122.57M 16.80M 8.14M
Income Taxes 10.89M 46.46M -15.17M 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations 21.67M 78.99M 34.44M 9.63M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 21.67M 78.99M 34.44M 9.63M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 21.67M 78.99M 34.44M 9.63M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
21.67M 78.99M 34.44M 9.63M
Preferred Dividends
Net Income Available To Common 21.67M 78.99M 34.44M 7.10M
Basic EPS from Continuing Ops. 1.14 4.23 1.88 -0.67
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 1.14 4.23 1.88 -0.67
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 1.14 4.23 1.88 -0.67
Basic Normalized Net Income/Share 1.14 4.23 1.88 n.a.
EPS fr Continuing Ops. 1.13 4.09 1.80 -0.67
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 1.13 4.09 1.80 -0.67
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 1.13 4.09 1.80 -0.67
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
1.13 4.09 1.80 n.a.
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with ENTA

Latest ENTA Headlines from TheStreet

More Financial News for ENTA

Press Releases for ENTA

See All Press Releases

Partner Headlines for ENTA

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter